Czechia· CZ-0207956
MONOTAB
A isosorbide mononitrate product, registered in Czechia by Zentiva, k.s., Praha. The same ATC class is registered in 13 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Isosorbide mononitrate is registered in 13 of 19 countries.
Countries holding a registration under ATC C01DA14 (isosorbide mononitrate), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 7 of them publish a price we can compare per daily dose
Isosorbide mononitrate · ATC C01DA14
13 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of isosorbide mononitrate costs, country by country.
Normalised to the WHO defined daily dose (40 mg), the median price runs from $0.078 in United States to $0.15 in Italy — a ×1.9 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Isosorbide mononitrate · price per daily dose (40 mg)
USD · FX 28 Sept 2026
- IT Italy$0.15
- US United States$0.078 (acquisition cost)
The record
At a glance
SÚKL (Czech Republic)- Manufacturer
- Zentiva, k.s., Praha
- Country
- Czechia (CZ)
- ATC code
- C01DA14
- ATC class
- Isosorbide mononitrate
- Defined daily dose
- 40 mg, O
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- June 22, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
275 interactions on record for isosorbide mononitrate.
Graded by severity as the source publishes them — 71 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Isosorbide mononitrate · interactions on record
275 records
- 71 moderate
- 1 minor
- 198 info
Most severe, free to view
- LidocainA01AE01moderate
- TetracainA01AE02moderate
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
5 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under C01DA14
Isosorbide mononitrate, as other registers publish it.
- United KingdomAngeze 10 tabletsOpus Pharmaceuticals Ltd
- United KingdomAngeze 20 tabletsOpus Pharmaceuticals Ltd
- CanadaAPO-ISMNAPOTEX INC
- United KingdomCarmil 20mg tabletsMilpharm Ltd
- United KingdomCarmil 40mg tabletsMilpharm Ltd
- United KingdomCarmil XL 60mg tabletsMilpharm Ltd
- United KingdomCarmil XL 60mg tabletsViatris UK Healthcare Ltd
- United KingdomChemydur 60XL tabletsAdvanz Pharma
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b9750046-8818-4111-b3ae-528fa4eccd61 GET /v1/drugs/b9750046-8818-4111-b3ae-528fa4eccd61?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "TBL NOB",
"source": "sukl",
"strength": "20MG",
"pack_size": "100(10X10)",
"substance": "4828",
"cz_kod_sukl": "0207956",
"product_type": "CH",
"registration_state": "R",
"registration_number": "83/123/03-C"
}See everything about isosorbide mononitrate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.